Toward More Uniform Methotrexate Dosing in Psoriasis
Toward More Uniform Methotrexate Dosing in Psoriasis"
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
With overwhelming support from some 200 experts worldwide, dosing of methotrexate (MTX) for psoriasis should start at 15 mg/week for most adults, though lower in those considered
"vulnerable" and in children, according to a new consensus statement.
That may not seem like big news, as it's in line with most dermatologists' and rheumatologists' practice. But in fact, surveys have shown wide variation in physicians' approach to MTX dosing
in psoriasis. The authors of the consensus statement, led by Astrid M. van Huizen, MD, of the University of Amsterdam, noted that some doctors prescribe as little as 5 mg/week or as much as
22 mg/week for initial dosing in adults.
"The variability in treatment regimens might have contributed to suboptimal treatment with MTX or early discontinuation of treatment because of limited efficacy or, in the case of
overtreatment, adverse effects," van Huizen and colleagues wrote in their statement, appearing in JAMA Dermatology.
Consequently, the Skin Inflammation and Psoriasis International Network (SPIN), comprising some 4,500 professionals in the field, asked its members to participate in a series of three
surveys about their beliefs and recommendations for methotrexate dosing. Just over 200 did so for the first round and 180 completed all three; 58 also participated in a consensus meeting
where proposals not achieving consensus through this process were discussed and refined further.
Seven SPIN leaders from Britain and continental Europe formed a working group to identify the main issues around MTX dosing that need standardization. They came up with seven topics -- test
dose, start dose, dosage adjustment, maximum dose, form of administration, switching formulations, and use of folic acid -- with consideration of how they might differ among adults,
"vulnerable patients," and children.
Proposed consensus statements included, for example: "Usually, MTX is administered in a single weekly dose," and "When starting MTX in vulnerable patients, start with a dosage of 7.5-10
mg/wk." In each survey round, participants rated their agreement with the statements on a nine-point scale: 1-3 indicated disagreement, 7-9 reflected agreement, and 4-6 was considered
neither agreeing nor disagreeing. Voters were asked to avoid the middle range whenever possible, as such votes would make it more difficult to achieve consensus.
At each round, participants could also propose their own new or reworded statements. In the end, 21 statements were brought forward to the third round, and 16 achieved what SPIN had defined
as consensus (no more than 15% of voters disagreeing).
Both of the two quoted above were agreed to. Others included: "Folic acid should be supplemented in all patients"; "Usually, MTX is administered orally"; and "In case of inefficacy or
insufficient effect, according to the treatment goals, it is preferred to switch the MTX route of administration from oral to subcutaneous."
Also achieving consensus were the preferred dosage for children ("around 10 mg/m2/wk"), more items on folic acid dosing, and a stipulation that efficacy shouldn't be assessed until patients
have been on the drug "at least 3-4" months.
Five proposals went to the consensus meeting for further discussion and voting, with four gaining consensus there. Two of these stated that test doses aren't needed for vulnerable patients
or children, respectively; one set the maximum weekly MTX dose at 25 mg for vulnerable patients, the same as for other adults; and the fourth called for folic acid to be given once weekly.
The one statement not achieving final consensus was, "The dosage of folic acid should be increased when increasing the dosage of MTX." Fully 93% of meeting participants disagreed with it,
which looks very much like consensus, but under SPIN's rules it had to be considered non-achieved.
This so-called eDelphi procedure had some limitations, van Huizen and colleagues noted. "Most participants were from Europe," the authors wrote, whereas the group had hoped to attract input
more widely. Their definition of consensus was somewhat arbitrary, and the focus on MTX and folic acid dosing meant that some related issues such as safety monitoring went unaddressed.
Perhaps most importantly, the agreed-upon statements are expert opinion, considered the weakest form of evidence for guidelines. SPIN leaders did link the proposals to published reports from
randomized trials, so they were founded to some extent on hard science. Nevertheless, the selections were not necessarily systematic or comprehensive.
John Gever was Managing Editor from 2014 to 2021; he is now a regular contributor.
Many of the roughly 200 authors reported relationships with pharmaceutical companies and other commercial entities.
Trending News
South korea mulls state control of school history textbooksGetty Images - Chung Sung-Jun South Korea's government may take back control over school history textbooks from pri...
Your brain could be controlling how sick you get — and how you recoverHundreds of scientists around the world are looking for ways to treat heart attacks. But few started where Hedva Haykin ...
Effect of oxygen on the frequency of chromosome aberrations produced by x-raysABSTRACT Mottram1 demonstrated that the effect of gamma- and X-radiations in inhibiting the growth of _Vicia faba_ root ...
Vaccination status and self-reported side effects after sars-cov-2 vaccination in relation to psychological and clinical variables in patients with muABSTRACT The recent SARS-CoV-2 pandemic and the vaccination campaign posed a challenge to patients with autoimmune disea...
Siloxanes and silazanes as activators for metathesis polymerizationsARTICLE PDF REFERENCES * V. Dragutan, A. T. Balaban, and M. Dimonie, “_Olefin Metathesis and Ring-Opening Polymerization...
Latests News
Toward More Uniform Methotrexate Dosing in PsoriasisWith overwhelming support from some 200 experts worldwide, dosing of methotrexate (MTX) for psoriasis should start at 15...
Nutrition, food and dietary care | veterans affairsOur registered dietitians can help you maintain or improve your health with good nutrition tailored to your needs. WHAT ...
Unser filmtipp: we live in time - vatican newsDie Köchin eines Restaurants und der Werbemanager eines Lebensmittelkonzerns lernen sich auf ebenso kuriose wie tragisch...
Hubbell shows market leadership with jump to 81 rs ratingOn Thursday, Hubbell (HUBB) reached a key performance benchmark, seeing its Relative Strength (RS) Rating jump into the ...
District mental healthcare plans for five low- and middle-income countries: commonalities, variations and evidence gapsDISTRICT MENTAL HEALTHCARE PLANS FOR FIVE LOW- AND MIDDLE-INCOME COUNTRIES: COMMONALITIES, VARIATIONS AND EVIDENCE GAPS ...